![Dexpanthenol: An Overview of its Contribution to Symptom Relief in Acute Rhinitis Treated with Decongestant Nasal Sprays | springermedizin.de Dexpanthenol: An Overview of its Contribution to Symptom Relief in Acute Rhinitis Treated with Decongestant Nasal Sprays | springermedizin.de](https://media.springernature.com/lw150/springer-static/cover/journal/12325/34/8.jpg?as=jpg)
Dexpanthenol: An Overview of its Contribution to Symptom Relief in Acute Rhinitis Treated with Decongestant Nasal Sprays | springermedizin.de
![(PDF) Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study (PDF) Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study](https://i1.rgstatic.net/publication/331549572_Effect_of_withdrawal_of_fusafungine_from_the_market_on_prescribing_of_antibiotics_and_other_alternative_treatments_in_Germany_a_pharmacovigilance_impact_study/links/5c9377c7299bf111693bf990/largepreview.png)
(PDF) Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study
![Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study | European Journal of Clinical Pharmacology Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study | European Journal of Clinical Pharmacology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00228-019-02650-z/MediaObjects/228_2019_2650_Fig1_HTML.png)
Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study | European Journal of Clinical Pharmacology
![Fusafungine-containing medicines should be withdrawn, says European Medicines Agency - The Pharmaceutical Journal Fusafungine-containing medicines should be withdrawn, says European Medicines Agency - The Pharmaceutical Journal](https://pharmaceutical-journal.com/wp-content/uploads/2021/01/young-man-using-nasal-spray-16-scaled.jpg)